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Immunosuppression induced by solar UVR is re-
garded as one of the major negative impacts of
sunlight on human health. Despite this immunosup-
pression, bacterial superinfections are rarely observed
after UVR exposure. A possible explanation for this
seeming paradox may be that although it suppresses
T-cell-mediated immune reactions, UVR induces the
release of cutaneous antimicrobial peptides—an
essential component of the innate immune system.
The ‘‘sunshine vitamin,’’ vitamin D, also appears to be
involved, as UVR suppresses the adaptive but induces
the innate immune response. T cells in the skin are the
critical cellular mediators of the vast majority of
inflammatory dermatoses, and thus probably more
harmful than beneficial. Hence, it is tempting to
speculate that a certain and constant level of im-
munosuppression by physiological UVR doses might
be beneficial, taming overshooting immune reactions.
At the same time, by inducing antimicrobial peptides,
these low UVR doses may foster the antibacterial
defense. Thus, suppression of the adaptive and
induction of the innate immune system by UVR may
be components of a physiological protection process.
These insights might have effect on the future
recommendations for daily sun protection.
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UVR emitted by the sun represents one of the most important
environmental factors affecting humans. Besides its well-
known beneficial and indispensable effects on human life,
UVR, in particular the middle wavelength range
(290–320 nm, UVB), can be a hazard to health by inducing
sunburn, photoallergic and phototoxic reactions, skin cancer,
and premature skin aging. UVB radiation exerts various
biological effects, including induction of erythema, pigmen-
tation, and vitamin D synthesis. In the mid-1970s, it was
recognized that UVB radiation is also capable of suppressing
the immune system.
UVR SUPPRESSES THE IMMUNE SYSTEM
The natal hour of photoimmunology was the seminal
recognition of an association between UVR and immuno-
suppression in photocarcinogenesis by Margret Kripke and
her co-workers. They proposed that skin tumors induced in
mice by chronic UVB irradiation have to be highly antigenic,
as these tumors were rejected when transplanted onto
syngeneic mice (Kripke, 1974). However, when the recipi-
ents were treated with immunosuppressive drugs, the
transplanted tumors were not rejected, implying that this
type of rejection was immunologic in nature. Most im-
portantly, rejection also did not occur when recipients were
exposed to low doses of UVB radiation instead of receiving
immunosuppressive drugs (Figure 1; Kripke et al., 1977).
The immunosuppressive properties of UVB radiation were
further confirmed over the following years in the model of
contact hypersensitivity (CHS), which is induced by epicu-
taneous application of contact allergens. After successful
sensitization, a significant ear swelling response can be
induced by painting a lower concentration of the same
contact allergen, which by itself would not cause a swelling
response in naive mice. Toews et al. (1980) confirmed the
findings of the Kripke group, reporting that application of a
contact allergen to the skin that had been exposed to low
UVB doses failed to induce CHS (Figure 2a).
However, their observations were even more far-reaching
demonstrating long-term suppression. Mice used in this study
could not be re-sensitized against the same contact allergen
at a later time point, despite the fact that the contact allergen
was applied on the skin which had not been UVR-exposed
(Figure 2b). This suppression was antigen-specific, as the very
same mice could be normally sensitized against other
unrelated contact allergens. This indicated that the initial
low-dose UVR exposure suppressed the immune system not
in a general but rather in a specific manner, a phenomenon
termed ‘‘immunotolerance.’’
Fisher and Kripke (1978) provided first evidence that UVR-
induced immunosuppression in the tumor model might be
mediated through T cells that exert suppressive activity.
Elmets et al. (1983) confirmed that UVR-induced immuno-
tolerance in the CHS model is mediated through T cells. They
showed that intravenous injection of T cells obtained from
mice that were made tolerant by the application of a contact
allergen onto the UVR-exposed skin rendered the recipients
unresponsive to the very same allergen. However, other
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immune reactions were not suppressed in these mice,
which confirmed the antigen specificity of this suppression
(Figure 2c). At that time, these cells were called T-suppressor
cells. Subsequently, several types of UVR-induced T-sup-
pressor cells have been described. These subtle differences
may be explained by different UVR doses (high versus
low doses), the types of antigen applied, and the strains of
mice used.
Presently, T-suppressor cells have been renamed regula-
tory T cells (Beissert et al., 2006). Numerous studies have
confirmed that UVR-induced regulatory T cells suppress the
immune system in an antigen-specific manner. The antigen
specificity distinguishes UVR-induced immunosuppression
from drug-induced immunosuppression. Different subtypes of
regulatory T cells are involved in UVR-induced immunosup-
pression, depending on the UVR dose, the type of antigen,
the route by which the antigen is administered, and the type
of immune reaction induced (Schwarz, 2008).
UVR ALSO SUPPRESSES THE IMMUNE SYSTEM IN
HUMANS
The vast majority of photoimmunological studies were
performed in vivo using animal models. Although various
in vitro studies were performed with human cells, the
question arose whether it is permissible to extrapolate the
findings of the animal models to the human system. In fact,
UVR appears to suppress the induction of CHS in humans as
well. Antigen-specific tolerance can be induced, although it
may develop in only 10% of exposed individuals (Yoshikawa
et al., 1990). However, other studies have reported that
almost all individuals tested could be suppressed by UVR
(Cooper et al., 1992; Kelly et al., 2000; Wolf et al., 2003).
The differences may be explained by the usage of different
UVR doses and different concentrations of the sensitizers.
UVR-INDUCED IMMUNOSUPPRESSION AND SKIN
CANCER
One of the major challenges of the immune system is to
protect from malignancy. Transformed cells can be recog-
nized as ‘‘foreign’’ and attacked by the immune system,
inducing a tumor immune response. This may apply for both
non-melanoma skin cancer and malignant melanoma. A
strong correlation exists between the risk for skin cancer and
immunosuppression. Individuals taking immunosuppressive
drugs, such as transplant patients, show a significantly
increased risk to develop skin cancer and this correlates with
the cumulative UVR exposure (Euvrard et al., 2003). Patients
with a positive history of skin cancer are more sensitive to
UVR-induced suppression of CHS responses than individuals





Figure 1. UVR inhibits the rejection of transplanted skin tumors. Chronic
UVR exposure induces squamous cell carcinomas in mice. These tumors are
immunogenic as they are rejected when transplanted into healthy mice.
However, the tumors are not rejected but grow progressively if the recipient
mice are treated with immunosuppressive drugs or alternatively exposed to










Figure 2. UVR inhibits sensitization and induces antigen-specific
immunotolerance. Epicutaneous application of a contact allergen
(e.g., DNFB) causes sensitization, which results in a contact hypersensitivity
(CHS) response upon application of a lower concentration on the ear. (a)
Painting of the contact allergen onto UVR-exposed skin does not result in
contact hypersensitivity (Toews et al., 1980). (b) The attempt to re-sensitize
UVR-exposed mice after 2 weeks by painting the contact allergen onto the
non-UVR-exposed skin (abdomen) also fails to induce contact hypersensitivity
(Toews et al., 1980). (c) Intravenous injection of T cells obtained from the
spleens and lymph nodes from mice, in which the contact allergen DNFB was
applied onto UVR-exposed skin, suppresses the induction of CHS against
DNFB in the recipients. In contrast, injection of the very same cells does not
inhibit the sensitization against other non-related allergens (e.g., oxazolone,
OXA) in recipient animals.
50 Journal of Investigative Dermatology (2010), Volume 130
T Schwarz
UV-Induced Immunosuppression
Various animal models have shown the negative effect of
UVR on host defense against skin tumors. UVR-induced
immunosuppression supports the outgrowth of transplanted
epithelial skin cancers and melanomas (Kripke, 1974; Kripke
and Fisher, 1976; Donawho and Kripke, 1991). Injection of
T cells activated in UV-irradiated mice by tumor antigen
exposure into naive mice inhibits tumor immunity and
enables the outgrowth of inoculated UVR-induced skin
tumors in the recipients (Ullrich and Kripke, 1984).
In turn, restoration or even enhancement of an immune
response by the topical or systemic application of immuno-
modulators, such as interferons or imiquimod, is a successful
and widely used strategy for the treatment of skin cancer and
its pre-stages (Hersey, 2004; Ooi et al., 2006). All this
supports the concept that the immunosuppressive properties
of UVR crucially contribute to photocarcinogenesis.
UVR-INDUCED IMMUNOSUPPRESSION AND
MICROBIAL INFECTIONS
Because of the suppression of the immune system, one would
expect increased susceptibility to infections after solar
exposure. Accordingly, exacerbations of infectious diseases
are often listed as another practical consequence of UVR-
induced immunosuppression. In fact, numerous experimental
models have shown that UVR suppresses immune responses
against bacterial, viral, and fungal infections (Chapman
et al., 1995). For example, mice that were immunized with
the herpes simplex virus developed severe ulcerated lesions
upon cutaneous herpes virus inoculation during which they
were exposed to UVR before inoculation (El-Ghorr and
Norval, 1996).
In contrast to the undisputed role of UVR-induced
immunosuppression in photocarcinogenesis, clinical evi-
dence for an enhanced frequency of infections after UVR
exposure is low. One exception might be herpes simplex,
which is well known to exacerbate upon UVR exposure in
susceptible persons (Norval, 2006). However, bacterial
superinfections even after extensive natural or artificial
UVR exposure are extremely rare, and impetiginization is
not at all a problem for patients with sunburn (Termorshuizen
et al., 2002). In contrast, impetiginized atopic skin can
improve upon UVR exposure without antibiotic or antiseptic
treatment (Silva et al., 2006). Hence, the question is obvious
how UVR as a regimen, which is known to be immunosup-
pressive, does not generally worsen but sometimes even
improves cutaneous bacterial infections.
ANTIMICROBIAL PEPTIDES: AN ESSENTIAL
COMPONENT OF THE INNATE IMMUNE SYSTEM
Two major types of immune responses have to be
differentiated, the innate and the adaptive one. The major
characteristics of the adaptive immune response,
mostly referred as the classical immune response, are
specificity and memory. Essential components of an adaptive
immune response are antigen-presenting cells, T cells,
and B cells.
Innate immune responses are characterized by the lack of
immunologic memory. These immune reactions are less
complicated than adaptive responses and developed earlier
in evolution (Medzhitov and Janeway, 2000). Nevertheless,
failures in these ‘‘primitive’’ immune responses can cause
severe, even fatal health problems. The innate response is
rapid and less controlled. Its essential components are
neutrophils, eosinophils, natural killer cells, mast cells,
cytokines, complement, and, as recently discovered, anti-
microbial peptides (AMPs; Zasloff, 1992).
To cope with an environment that is full of microorgan-
isms, plants and invertebrates produce various very effective
AMPs (Wong et al., 2007). Epithelia of vertebrates can also
function as a source of such peptides (Braff and Gallo, 2006);
human epithelia, including the epidermis, secrete AMPs and
thereby mount an innate chemical defense shield (Harder
and Schro¨der, 2005). The first AMP isolated from human skin
was human b-defensin (HBD-2; Harder et al., 1997).
Additional AMPs produced in the skin include HBD-3
(Harder et al., 2001), RNase 7 (Harder and Schro¨der,
2002), psoriasin (Gla¨ser et al., 2005), the cathelicidin LL-37
(Frohm et al., 1997), and dermcidin (Schittek et al., 2001).
The major source of HBD-2, HBD-3, RNase 7, and psoriasin
are keratinocytes. LL-37 can be produced by keratinocytes,
but its major source appears to be leukocytes. Dermcidin is a
sweat gland-derived AMP. HBD-2 is the most bactericidal for
Gram-negative bacteria (Harder et al., 1997), psoriasin for
Escherichia coli (Gla¨ser et al., 2005), whereas HBD-3 and
RNase 7 cover a broad antimicrobial spectrum being active
even against methicillin-resistant Staphylococci and vanco-
mycin-resistant Enterococci (Harder and Schro¨der, 2002).
The essential protective role of keratinocyte-derived AMPs
was recently shown by an overgrowth of E. coli on human
skin upon injection of antibodies that neutralized psoriasin
(Gla¨ser et al., 2005). This study underscored the concept that
AMPs, and thus the innate immune system is more relevant
for the antibacterial defense than the adaptive immune
system.
UVR INDUCES AMPS
This concept and the clinical observation that UVR exposure
does not worsen bacterial infections of the skin gave rise to
the hypothesis that UVR might not suppress but rather
induce keratinocyte-derived AMPs. Further studies have
shown that UVR induces the release of HBD-2, HBD-3,
RNase 7, and psoriasin by keratinocytes in vitro (Seo et al.,
2001; Gla¨ser et al., 2009). Enhanced protein levels of AMPs
were detected in biopsies from UVR-exposed volunteers.
Immunohistochemical analyses have shown that AMPs are
not equally expressed throughout the entire epidermis but
almost exclusively in the upper layers. UVR exposure
does not alter this distribution but enhances the expression
pattern (Gla¨ser et al., 2009). The predominant expression of
AMPs in the uppermost layers appears to be beneficial
from the biological point of view since the first contact
with microorganisms occurs here. Interindividual variations
in the inducibility of AMPs by UVR have been
observed, leading to speculation that high and low
responders exist, just as proposed for UVR-induced




VITAMIN D: AN INDUCER OF AMPS
A strong interindividual variation was also noticed in the first
study describing in vivo induction of LL-37 mRNA expression
by UVR in humans (Mallbris et al., 2005). The induction
correlated with the mRNA expression of the vitamin D
receptor, suggesting that UVR which induces vitamin D
synthesis might induce LL-37 through vitamin D. In addition,
vitamin D is a direct regulator of several antimicrobial innate
immune responses (Harder et al., 2000; Wang et al., 2004;
Schauber et al., 2007).
The strongest indication for a link between vitamin D and
induction of an innate immune response was provided by a
study, which initially aimed to elucidate the antimicrobial
activity of macrophages against Mycobacterium tuberculosis
(Liu et al., 2006). Activation of Toll-like receptors on human
monocytes induced the expression of the vitamin D receptor
and CYP 27B1. The latter is the enzyme converting pre-
vitamin D into active vitamin D, which then binds to the
vitamin D receptor induced in the monocytes. This autocrine
stimulation of the monocytes by vitamin D induced the
release of LL-37, which finally killed M. tuberculosis.
Differences in the ability of human populations to produce
vitamin D may contribute to the susceptibility to microbial
infections. As vitamin D is induced by the UVB spectrum of
solar radiation, one could speculate that induction of AMPs
by UVR is mediated through the induction of vitamin D.
However, despite a recent report that ketoconazole, an
inhibitor of vitamin D synthesis, suppressed UVR-mediated
induction of AMPs in mice (Hong et al., 2008), no functional
studies in humans have been carried out so far to prove this
hypothesis.
The study by Liu et al. (2006) has several far-reaching
implications. It might explain why American blacks, who
have substantially lower serum vitamin D levels than whites,
as a consequence of greater UVR absorption by their darker
skin pigmentation, are more susceptible to infections
with M. tuberculosis (Zasloff, 2006). Theoretically, the
administration of vitamin D should augment the microbicidal
activity of monocytes from black people (Zasloff, 2006).
Finally, this study answers the question how sunlight can treat
tuberculosis, a phenomenon observed more than a century
ago by Nils Ryberg Finsen, who was awarded with the
Nobel prize for this discovery in 1903 (Zasloff, 2006). Over
the decades, it was one of the major challenges
for immunologists and, in particular, photoimmunologists
how to explain the tuberculostatic effect of sunlight, which is
immunosuppressive and thus according to conventional
ideas would worsen tuberculosis. The recent insight
that the innate immune system and, in particular, AMPs are
more relevant in the fight against tuberculosis than the
adaptive immune response that gives an answer to this
question. It also explains the therapeutic effects of the
climate cures in the past, which initially were believed to
be due to the fresh and clean air, but in fact might have
been acted through vitamin D synthesis induced by
natural sunlight in the affected individuals, the majority of
whom in those days may have been prone to vitamin D
deficiency.
UVR-INDUCED IMMUNOSUPPRESSION: GOOD OR
BAD?
Exposure to UVR doses that are only 30–50% as high as what
is required to cause barely detectable sunburn, suppresses
immunity in humans. Therefore, normal daily outdoor
activities are likely to cause some degree of immunosuppres-
sion in a large proportion of humans. It is rather striking that
UVR at such low doses suppresses, in particular, T-cell-
mediated immune reactions. The skin is an organ that is
constantly exposed to potential allergens. In addition, it is
quite prone to autoimmunity, as many autoimmune diseases
affect the skin (Casciola-Rosen et al., 1994). Various
transgenic mouse models have shown that immunological
manipulations exclusively in the skin, including overexpres-
sion of co-stimulatory molecules on basal keratinocytes, not
only result in an inflammatory skin phenotype but also with
time cause systemic autoimmunity (Mehling et al., 2001). The
vast majority of allergic and autoimmune reactions are T-cell-
driven (Robert and Kupper, 1999), yielding the concept that
T cells in the skin are more harmful than beneficial. It is
tempting to speculate that a certain degree of constant
immunosuppression by daily solar exposure may prevent the
induction of these immune responses. This hypothesis is also
supported by the concept that polymorphic light eruption is
caused by a flaw in the immunoregulatory response to UVR
as patients suffering from polymporphic light eruption were
found less suppressed in their CHS response by UVR than
healthy controls (van de Pas et al., 2004; Palmer and
Friedmann, 2004; de Gruijl, 2008).
On the other hand, induction of AMPs by the same UVR
doses can be protective. UVR exposure results in a disruption






Figure 3. UVR induces the release of antimicrobial peptides and suppresses
sensitization against contact allergens. UVR disrupts the corneal layer,
which enables the penetration of bacteria and contact allergens (Jiang et al.,
2006). UVR stimulates keratinocytes to release antimicrobial peptides (AMPs),
which attack the invading microbes (Gla¨ser et al., 2009). UVR alters the
capacity of Langerhans cells (LC) to present antigens including contact
allergens. This finally does not result in sensitization but in the induction of
regulatory T cells (Treg cells), which suppress the contact hypersensitivity
response against these antigens (Schwarz, 2008). Conversion of pre-vitamin D
(7-dehydrocholesterol, 7-DHC) into vitamin D 3 (D3) by UVR might be
involved in these processes.
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increase the risk for bacterial infections. Thus, induction of
AMPs by UVR as a counter-regulatory phenomenon may be
beneficial (Zasloff, 2005). This might also be the reason for
the high efficacy of phototherapy in T-cell-mediated derma-
toses without causing infectious side effects well known for
conventional immunosuppressive drugs.
Taken together, there is accumulating evidence that UVR
in physiological doses exerts diverse effects on the immune
system; it induces the innate but suppresses the adaptive
immune system. Both effects may be beneficial, protecting
from microbial infections on the one hand, but toning down
allergic and autoimmune reactions on the other hand
(Figure 3). These effects could be a part of a protection
mechanism evolved during evolution. This argues against
total sun protection, and thus might have important implica-
tions for future sun protection strategies. The appropriate
physiological daily dose certainly will vary between the
individuals and remains to be defined. Despite these new
insights, excessive and chronic natural as well as artificial
UVR exposure will, however, remain one of the major
environmental threats for human health.
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